Biomedical Enterprises Inc

medical devices

About

Biomedical Enterprises, Inc. (BME), a "C" corporation registered in Maryland, is focused on the validation and commercialization of an apparatus to treat systemic infections for which there is no known treatment available with heat and ultraviolet light (UVL). This product fulfills an unmet demand and the founder's knowledge of dialysis and experience treating patients with blood infections in intensive care units allowed identifying this solution. Previously, BME has validated an innovative design of a dialysis needle with $1.5 million funds awarded by the National Institute of Health (NIH). The performed research studies demonstrated that the new needle, the BME needle, causes less damage to white cells, a smaller release of pro-inflammatory cytokines, and less inflammation. A discovery of great clinical significance. The needle received the NIH's support through a commercialization assistance program.

Technologies

GoDaddy Hosting Varnish Google Font API WordPress.org Mobile Friendly AI

Keywords

medical devices medical devices for hemodialysis medical equipment manufacturing nih-supported devices biotechnology hemodialysis device innovation regenerative medicine healthcare technology healthcare equipment and supplies manufacturing targeted temperature management artificial intelligence in healthcare patented medical devices government innovative medical devices artificial intelligence life-saving devices b2b product design urine cancer screening ai dialysis needle uv plasma treatment device design medical device development unmet medical needs medical equipment and supplies manufacturing medical research and development ultraviolet light treatment cancer cell identification medical device commercialization blood circuit components

Location

5241 Crown St, Bethesda, Maryland, United States, 20816-1407

Related Companies

Companies in the same industry